Teladoc Health, Inc. (NYSE:TDOC – Get Rating) CAO Richard J. Napolitano sold 1,384 shares of the company’s stock in a transaction on Thursday, March 2nd. The shares were sold at an average price of $25.36, for a total transaction of $35,098.24. Following the sale, the chief accounting officer now directly owns 5,030 shares in the company, valued at approximately $127,560.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Teladoc Health Stock Up 5.7 %
Shares of Teladoc Health stock opened at $26.88 on Monday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.29 and a quick ratio of 3.15. Teladoc Health, Inc. has a 1 year low of $21.60 and a 1 year high of $77.50. The firm’s 50-day moving average is $27.22 and its two-hundred day moving average is $27.99. The stock has a market cap of $4.37 billion, a price-to-earnings ratio of -0.32 and a beta of 1.08.
Teladoc Health (NYSE:TDOC – Get Rating) last issued its earnings results on Wednesday, February 22nd. The health services provider reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.04. Teladoc Health had a negative net margin of 567.53% and a negative return on equity of 4.35%. The company had revenue of $637.71 million for the quarter, compared to analysts’ expectations of $633.71 million. As a group, research analysts expect that Teladoc Health, Inc. will post -1.41 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Institutional Trading of Teladoc Health
Several hedge funds have recently modified their holdings of TDOC. MetLife Investment Management LLC purchased a new stake in shares of Teladoc Health during the first quarter valued at about $218,000. Panagora Asset Management Inc. lifted its position in shares of Teladoc Health by 18.8% during the first quarter. Panagora Asset Management Inc. now owns 16,710 shares of the health services provider’s stock valued at $1,205,000 after buying an additional 2,640 shares during the last quarter. Rhumbline Advisers lifted its position in shares of Teladoc Health by 2.3% during the first quarter. Rhumbline Advisers now owns 130,916 shares of the health services provider’s stock valued at $9,443,000 after buying an additional 2,921 shares during the last quarter. Great West Life Assurance Co. Can lifted its position in shares of Teladoc Health by 10.8% during the first quarter. Great West Life Assurance Co. Can now owns 107,908 shares of the health services provider’s stock valued at $8,237,000 after buying an additional 10,559 shares during the last quarter. Finally, Raymond James Trust N.A. lifted its position in shares of Teladoc Health by 7.8% during the first quarter. Raymond James Trust N.A. now owns 11,451 shares of the health services provider’s stock valued at $826,000 after buying an additional 827 shares during the last quarter. 84.14% of the stock is owned by hedge funds and other institutional investors.
Teladoc Health Company Profile
Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure.
Recommended Stories
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
